The Expansion of Bispecifics in Myeloma -What’s Next? Alfred Garfall, MD

İndir

35:45

CAR T Therapy in Myeloma - Inside the Revolution | Krina Patel, MD

42:06

Myeloma 101: Understanding Multiple Myeloma, Risk Factors, Diagnosis & Treatments Explained

33:44

Innovations in Myeloma Therapies: Promise of ADCs, CELMoDs, BCL2 Inhibitors, & SINEs | Dan Vogl, MD

31:29

Navigating Risks and Rewards- Immunotherapies in Myeloma Care | Adam Cohen, MD

29:19

Expanding Myeloma Treatments: Power of Bispecific & Trispecific Antibodies| Dr. Aravind Ramakrishnan